Patents Assigned to OXURION NV
  • INTEGRIN ANTAGONISTS
    Publication number: 20210198258
    Abstract: The present invention relates to novel integrin antagonists of Formula (I) and their use as a medicament, in particular for inhibiting neovascularization.
    Type: Application
    Filed: August 19, 2019
    Publication date: July 1, 2021
    Applicant: Oxurion NV
    Inventors: Ove Pedersen, Elke Vermassen
  • Integrin antagonists
    Patent number: 10703752
    Abstract: The present invention relates to novel integrin antagonists of Formula I and their use as a medicament, in particular for inhibiting neovascularization.
    Type: Grant
    Filed: August 19, 2019
    Date of Patent: July 7, 2020
    Assignee: OXURION NV
    Inventors: Ove Pedersen, Elke Vermassen
  • INTEGRIN ANTAGONISTS
    Publication number: 20200055849
    Abstract: The present invention relates to novel integrin antagonists of Formula I and their use as a medicament, in particular for inhibiting neovascularization.
    Type: Application
    Filed: August 19, 2019
    Publication date: February 20, 2020
    Applicant: OXURION NV
    Inventors: Ove Pedersen, Elke Vermassen